NL7611088A - N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan. - Google Patents

N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan.

Info

Publication number
NL7611088A
NL7611088A NL7611088A NL7611088A NL7611088A NL 7611088 A NL7611088 A NL 7611088A NL 7611088 A NL7611088 A NL 7611088A NL 7611088 A NL7611088 A NL 7611088A NL 7611088 A NL7611088 A NL 7611088A
Authority
NL
Netherlands
Prior art keywords
isoglutamine
muramyl
alanyl
acetyl
preparation
Prior art date
Application number
NL7611088A
Other languages
English (en)
Dutch (nl)
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of NL7611088A publication Critical patent/NL7611088A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL7611088A 1975-10-09 1976-10-07 N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan. NL7611088A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7530948A FR2326930A1 (fr) 1975-10-09 1975-10-09 Agents hydrosolubles depresseurs non specifiques des reponses immunitaires

Publications (1)

Publication Number Publication Date
NL7611088A true NL7611088A (nl) 1977-04-13

Family

ID=9161007

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7611088A NL7611088A (nl) 1975-10-09 1976-10-07 N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan.

Country Status (10)

Country Link
US (1) US4101649A (fr)
JP (1) JPS5257120A (fr)
AU (1) AU522089B2 (fr)
BE (1) BE847103A (fr)
CA (1) CA1091651A (fr)
CH (1) CH616943A5 (fr)
DE (1) DE2645610C2 (fr)
FR (1) FR2326930A1 (fr)
GB (1) GB1562734A (fr)
NL (1) NL7611088A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
US4391800A (en) * 1979-04-27 1983-07-05 Merck & Co., Inc. Immunologically active peptidyl disaccharides and methods of preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
US4357322A (en) * 1980-07-29 1982-11-02 Syntex (U.S.A.) Inc. Method of preventing, reducing or inhibiting inflammation
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4765980A (en) * 1986-04-28 1988-08-23 International Minerals & Chemical Corp. Stabilized porcine growth hormone
SI9300212A (en) * 1993-04-22 1994-12-31 Univ Ljubljani Novel N-acyldipeptides, process for the preparation thereof and pharmaceutical composition containing the same
WO2016138286A1 (fr) 2015-02-26 2016-09-01 Stc.Unm Irgm et commandes de l'autophagie de précision contre des maladies bactériennes et inflammatoires et procédés de détection de l'autophagie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
DE2645610C2 (de) 1984-10-25
AU1867676A (en) 1978-04-20
BE847103A (fr) 1977-04-08
US4101649A (en) 1978-07-18
FR2326930A1 (fr) 1977-05-06
GB1562734A (en) 1980-03-12
AU522089B2 (en) 1982-05-13
JPS5257120A (en) 1977-05-11
FR2326930B1 (fr) 1979-09-14
CH616943A5 (fr) 1980-04-30
CA1091651A (fr) 1980-12-16
JPS618079B2 (fr) 1986-03-11
DE2645610A1 (de) 1977-04-21

Similar Documents

Publication Publication Date Title
NL7613431A (nl) Werkwijze voor de bereiding van o-hydroxybenzal- dehyden.
NL7608674A (nl) Werkwijze voor de bereiding van canthaxanthine.
NL7610066A (nl) Werkwijze voor de bereiding van amidoxim deri- vaten.
NL7606994A (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7611088A (nl) N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan.
NL7608206A (nl) Thiazolidinederivaten en werkwijze voor hun bereiding.
NL7600512A (nl) Werkwijze voor de bereiding van 2-aminobutanol-1.
NL7609939A (nl) Werkwijze voor de bereiding van n-acylhydroxyaryl- glycinen.
NL7611424A (nl) Werkwijze voor de bereiding van ethylvanadaat.
NL7603629A (nl) Werkwijze voor de bereiding van nieuwe alkyl- amino-erythromycinen en zouten daarvan.
NL184952C (nl) Werkwijze voor de bereiding van cyclohexanonoxim.
NL7607505A (nl) Werkwijze voor de bereiding van sulfamylbenzyl- aminen.
NL7611271A (nl) Werkwijze voor de bereiding van 4-alkylthio- semicarbaziden.
NL7602269A (nl) Werkwijze voor de bereiding van entpolymeren.
NL7607616A (nl) Werkwijze voor de bereiding van lactonen.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL186160C (nl) Werkwijze voor de bereiding van theaspiran.
NL7603671A (nl) Werkwijze voor de bereiding van een deodorans en een dergelijk deodorans.
NL7607693A (nl) Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten.
NL7612021A (nl) Polyhydroxyfenolen en werkwijze voor de berei- ding daarvan.
NL7611159A (nl) Thiazolidinederivaten en werkwijze voor hun bereiding.
NL7609877A (nl) Werkwijze voor de bereiding van radio-actief gemerkt orgoteine.
NL7706439A (nl) Werkwijze voor de bereiding van bicyclo-dode- cylperoxydicarbonaat en toepassing daarvan.
NL7605669A (nl) Werkwijze voor de bereiding van lactonen.
NL7601670A (nl) Aminopyrrool derivaten en werkwijzen voor de bereiding en toepassing daarvan.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed